4772.TWO TWO
Taiwan Speciality Chemicals Corporation
1W: +14.9%
1M: +7.7%
3M: +1.2%
YTD: -8.3%
1Y: +22.1%
3Y: +252.4%
NT$281.50 ($8.86)
+0.00 (+0.00%)
Weekly Expected Move ±6.8%
NT$243
NT$262
NT$282
NT$301
NT$320
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$947M
+79.0% ▲
5Y CAGR: +30.5%
Capital Expenditures
$216M
-372.9% ▼
5Y CAGR: +79.1%
Free Cash Flow
$731M
+51.3% ▲
5Y CAGR: +25.1%
Dividends Paid
$295M
-113.7% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1.3B
+125.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $194M | $187M | $139M | $386M | $620M |
| Depreciation & Amort. | $133M | $144M | $119M | $92M | $125M |
| Stock-Based Comp. | $0 | $0 | $0 | $2M | $0 |
| Change in Working Capital | $23M | -$23M | -$24M | $45M | $12M |
| Other Non-Cash Items | -$5M | -$7M | -$376K | $5M | $190M |
| Operating Cash Flow | $345M | $301M | $235M | $529M | $947M |
| — Investing Activities — | |||||
| Capital Expenditures | -$42M | -$95M | -$101M | -$46M | -$217M |
| Acquisitions (Net) | $483K | $1M | $966K | $0 | -$2.2B |
| Investment Purchases | $0 | $0 | $0 | -$1.0B | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $1.0B |
| Other Investing | -$616K | -$239K | $30K | -$334K | $89K |
| Investing Cash Flow | -$42M | -$94M | -$100M | -$1.0B | -$1.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$270M | -$60M | $0 | -$112K | $2.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$90M | -$94M | -$138M | -$295M |
| Other Financing | -$167K | -$483K | -$251K | -$89K | -$7M |
| Financing Cash Flow | -$270M | -$150M | -$94M | $1.1B | $1.7B |
| Net Change in Cash | $32M | $57M | $40M | $571M | $1.3B |
| Cash End of Period | $58M | $115M | $155M | $726M | $2.0B |
| Free Cash Flow | $302M | $206M | $133M | $483M | $731M |